Aio! is a new Finnish diagnostic method for rapidly diagnosing an acute myocardial infarct when a patient with chest pains arrives at the hospital or consults a doctor.
The diagnostic system Aio! has been developed by Innotrac Diagnostics Oy with the goal of rapidly and accurately identifying in a patient-friendly way the markers secreted into the blood in connection with a myocardial infract. On the basis of the test result, the patient suffering from a myocardial infract can immediately be directed to receive the right kind of treatment.
"The key benefits of Aio! are its rapidity, reliability and convenience. We have developed dry chemistry to identify the compounds that indicate the disease. The test can be taken from whole blood, plasma or serum. The test results obtained through this rapid method of testing are as reliable as those obtained through central laboratory analyses. The disease can thus be diagnosed and its advancement can be monitored while electrocardiogram analysis is performed. If no markers indicating a myocardial infarct are found, the doctor can start to look for other reasons for the symptoms without delay," Managing Director Antti Iitiä of Innotrac Diagnostics Oy states.
Mira Banerjee-Rantala | alfa
Usher syndrome: Gene therapy restores hearing and balance
25.09.2017 | Institut Pasteur
MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer
25.09.2017 | Case Western Reserve University
A warming planet
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
25.09.2017 | Power and Electrical Engineering
25.09.2017 | Health and Medicine
25.09.2017 | Physics and Astronomy